The evolving landscape of predictive biomarkers in immuno‐oncology with a focus on spatial technologies

Immunotherapies have shown long‐lasting and unparalleled responses for cancer patients compared to conventional therapy. However, they seem to only be effective in a subset of patients. Therefore, it has become evident that a greater understanding of the tumor microenvironment (TME) is required to u...

Ausführliche Beschreibung